Loading...
Search for:
adaptive-immunity
0.005 seconds
Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues
, Article Journal of Medical Virology ; Volume 92, Issue 11 , May , 2020 , Pages 2257-2259 ; Noorbakhsh, F ; Mohebbi, S. R ; Ghaemi, A
John Wiley and Sons Inc
2020
CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
, Article Cancer Cell International ; Volume 20, Issue 1 , September , 2020 ; Tafsiri, E ; Cho, W. C. S ; Ghaemi, A ; Sharif University of Technology
BioMed Central Ltd
2020
Abstract
Cancer immunotherapy has been emerged as a promising strategy for treatment of a broad spectrum of malignancies ranging from hematological to solid tumors. One of the principal approaches of cancer immunotherapy is transfer of natural or engineered tumor-specific T-cells into patients, a so called "adoptive cell transfer", or ACT, process. Construction of allogeneic T-cells is dependent on the employment of a gene-editing tool to modify donor-extracted T-cells and prepare them to specifically act against tumor cells with enhanced function and durability and least side-effects. In this context, CRISPR technology can be used to produce universal T-cells, equipped with recombinant T cell...